Clinical trials
General Population (no Specific Condition or Disease) clinical trials
Below are recruiting general population (no specific condition or disease) clinical trials, each written for real people, not researchers. We’re tracking 10,802 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06507007Recruiting
Inner ear function in Turner syndrome
This study looks at why some people with Turner syndrome have inner ear problems. It uses MRI and CBCT scans to understand the genetic and epigenetic causes.
HerningAges 18–60 - NCT06507345Recruiting
Non-opioid pain relief after breast surgery
This trial tests whether non-opioid pain medicines can effectively control pain after mastectomy or lumpectomy, allowing you to go home the same day without needing strong opioids.
Montreal, QuebecAges 18 years+ - NCT06507657RecruitingEarly Phase 1
Empagliflozin for heart health in older adults
This study tests whether a medication called empagliflozin (a diabetes drug) can improve heart function in older adults with high blood pressure and obesity who are at risk for heart failure but do not have it yet. You would take the pill daily and have heart ultrasounds to check your heart's health.
Minneapolis, MinnesotaAges 60 years+ - NCT06508086Recruiting
Pilonidal sinus study for symptomatic patients
This trial tests a treatment for pilonidal sinus, a small tunnel in the skin near the tailbone that can cause pain and infection. It looks at how well the procedure works for people with symptoms but without complications.
SohagAges Any age - NCT06508749RecruitingPhase 1/Phase 2
Testing antibody therapy for HIV in children
This study tests whether a combination of special antibodies (bNAbs) can help control HIV without daily medication. It involves several steps and is for children who are already doing well on ART.
FrancistownAges 6 months–25 years - NCT06509308Recruiting
Understanding illness expectations in COPD patients
This study looks at what people with COPD expect from their illness and how those expectations affect their daily life. It involves answering questionnaires and simple tests.
MilanAges 18 years+ - NCT06509659Recruiting
Methacholine challenge test in healthy adults
This trial tests how healthy adults' lungs react to a substance called methacholine. It helps doctors understand normal lung responses and can be used for comparison with people who have asthma.
ElsinoreAges 18–65 - NCT06509893RecruitingPhase 4
Ticagrelor alone after stent placement
This study tests if a single blood thinner (ticagrelor) works well enough after getting a heart stent, instead of the usual two blood thinners. It may simplify your daily medication routine.
Shiraz, FarsAges 20–80 - NCT06509945Recruiting
Donor stem cell transplant for high-risk T-cell lymphoma
This trial tests giving a donor stem cell transplant (called allo-PBSCT) as the first treatment after chemotherapy for people with high-risk peripheral T-cell lymphoma. It may help prevent the lymphoma from coming back.
Shanghai, Shanghai MunicipalityAges 18–70 - NCT06510322RecruitingEarly Phase 1
Sildenafil for LVAD support
This trial tests whether sildenafil (the drug in Viagra) can help reduce blood vessel changes in people with a left ventricular assist device (LVAD). It aims to improve heart-pump function and overall health.
The Bronx, New YorkAges 18 years+ - NCT06510699RecruitingPhase 2
Genetics to improve fungal infection treatment
This trial tests if using genetic information can help doctors choose the right dose of the antifungal drug voriconazole. It aims to improve treatment and reduce side effects for people with fungal infections.
Seattle, WashingtonAges 2 years+ - NCT06511297Recruiting
How aging and weight affect health: a deep-dive study
This study looks at how aging and body weight affect health and metabolism. Researchers will collect detailed measurements (like scans and blood tests) to understand why some people age better than others. You may join if you are in one of five age/weight groups.
Vienna, State of ViennaAges 18 years+ - NCT06511284Recruiting
Nutrition therapy for swallowing problems after breathing tube removal
This study tests whether specialized nutrition therapy can help patients who have trouble swallowing after a breathing tube is removed. The goal is to improve recovery and quality of life for people who need a feeding tube after leaving the hospital.
Mexico CityAges 18 years+ - NCT06512493Recruiting
South East Netherlands Heart Registry
This is a heart registry that collects information from all patients to get a complete picture of heart care in the region. By including everyone, it aims to improve future treatments without bias.
Heerlen, LimburgAges Any age - NCT06512714Recruiting
Mycetoma medical records study
This study looks back at medical records of people diagnosed with mycetoma. It aims to collect data to better understand this rare infection, which could help improve future diagnosis and treatment.
ChandigarhAges Any age - NCT06512935Recruiting
Ventilator study for preterm infants with lung recovery
This study tests a new way of setting the ventilator for preterm babies born before 34 weeks who are still on a breathing machine. It aims to improve lung healing and heart function by finding the best pressure settings. The results could help your baby breathe more comfortably.
Birmingham, AlabamaAges 1 week–4 weeks - NCT06512792Recruiting
Study on mobile app for managing inflammatory bowel disease
This study tests if a mobile app can help manage your inflammatory bowel disease (IBD) from home. You may be eligible if you have IBD that has been active in the last two years and you are between 18 and 75 years old.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06513156Recruiting
Care support for hospitalized patients with drug-related infections
This study is for people who are in the hospital with a serious infection caused by injection drug use. It aims to provide better care and support while you are in the hospital and after you leave.
Washington D.C., District of ColumbiaAges 18 years+ - NCT06513234RecruitingPhase 2
Orelabrutinib and Obinutuzumab for untreated marginal zone lymphoma
This trial tests a combination of two targeted drugs, orelabrutinib and obinutuzumab, for people with a type of slow-growing lymphoma called marginal zone lymphoma who have not had any previous treatment. The goal is to see if this combination can shrink or control the cancer with manageable side effects.
TianjinAges 18 years+ - NCT06514170Recruiting
Stomach and bowel function after aortic surgery
This study looks at how stomach and bowel function changes after major aortic surgery. It may help doctors understand and prevent digestive problems in patients who need extended time on a ventilator after surgery.
Mexico City, TlalpanAges 18 years+ - NCT06514079Recruiting
Steroid injection for stubborn esophageal strictures in children
This trial tests whether adding a steroid injection to esophageal dilation helps children with narrowings that keep coming back. If you have a child with a stubborn narrowing that has already needed dilation, this treatment might help keep it open longer.
Cairo, SelectAges 2–14 - NCT06515106Recruiting
Living with LGI1 encephalitis: a study on long-term symptoms
This study looks at symptoms, biomarkers, and mechanisms of the chronic phase of LGI1 antibody-mediated encephalitis. It aims to understand what happens after the acute stage and how to better manage long-term effects.
Barcelona, CataloniaAges Any age - NCT06515314RecruitingPhase 1
TCR-T cell therapy for AFP-positive liver and other cancers
This trial tests an experimental cell treatment called HRYZ-T102 TCR-T for people with advanced liver cancer or other solid tumors that make a protein called AFP. The treatment uses your own immune cells, modified in a lab to target and kill cancer cells.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06516341Recruiting
Predicting bowel recurrence after surgery for chronic inflammation
This study follows patients with Crohn's disease or ulcerative colitis to see how their intestine heals after surgery. It looks for signs that can predict whether inflammation will return or complications will happen.
Milan, ItalyAges 18–69
Hear when a new General Population (no Specific Condition or Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for general population (no specific condition or disease)?
- Yes. Clin2 currently lists 10,802 recruiting general population (no specific condition or disease) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a general population (no specific condition or disease) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a general population (no specific condition or disease) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.